Genuine Parts Company vs GeneDx Holdings Corp — how do they compare? Genuine Parts Company trades at $133.81 (market cap $18.62B), while GeneDx Holdings Corp trades at $81.93 (market cap $2.44B). The key difference: Genuine Parts Company is far larger — about 7.6× GeneDx Holdings Corp's market cap, and Genuine Parts Company pays a 3.15% dividend while GeneDx Holdings Corp pays none. Which is the better fit depends on your goals.
| GPC | WGS | |
|---|---|---|
Market Cap | $18.62B | $2.44B |
Sector | Consumer Cyclical | Technology |
52-Week High | $149.26 | $167.51 |
52-Week Low | $92.47 | $34.51 |
Enterprise Value | $24.72B | $2.48B |
Dividend Yield | 3.15% | — |
Signals from Pluang's Aura AI — not financial advice
GPC trades at $133.47, down 0.8% today, with a bullish technical trend and strong institutional support. Recent Q2 2026 earnings beat estimates with EPS of $2.15 versus $2.08 expected, driven by 6% sales growth. The stock is near its 52-week high, supported by a consensus price target of $148.67, though net income margins remain thin at 0.13%.
Outlook is positive with analyst consensus leaning buy, but risks include compressed profitability and high P/E ratio. The dividend yield adds income appeal, yet margin pressures from inflation and competition warrant caution for growth-focused investors.
GeneDx Holdings Corp (WGS) trades at $82.07, up 5.38% in the past 24 hours, with technical indicators showing a bullish trend. The stock beat Q2 2026 EPS estimates but reported negative net income margins. Recent news highlights product expansion and institutional buying interest, though class-action lawsuits pose near-term sentiment risks.
Outlook is mixed: strong analyst buy ratings (90.9%) and a $79.25 consensus target suggest upside, but high valuation multiples and persistent losses require caution. Key risks include profitability challenges and legal overhangs, while revenue growth and market positioning offer long-term potential.
Trailing returns across standard periods
Latest headlines on both assets
Genuine Parts sells automotive parts (about two thirds of net sales) and industrial components. The company sells vehicle parts to commercial and retail customers through roughly 9,700 stores worldwide, most of which are independently owned. Its industrial unit, primarily operating under the Motion Industries banner in the United States, supplies bearings, power transmission, industrial automation, hydraulic, and pneumatic components to maintenance, repair, and OEM clients.
Read more on GPC →GeneDx is a patient-centered health intelligence company that specializes in transforming healthcare through the application of genomics. It combines advanced technology with one of the world's largest rare disease genomic datasets to provide clinical-grade exome and genome sequencing, enabling precise and rapid diagnosis for patients with complex medical conditions.
Read more on WGS →